OncoSec Medical/ US68234L4059 /
| 23/06/2023 21:59:33 | Chg. -0.18 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.28USD | -39.79% | 87,178 Turnover: 27,863.43 |
-Bid Size: - | -Ask Size: - | 0.45 | 0.25 |
GlobeNewswire
15/12/2021
Skye Bioscience Expands Board of Directors with the Appointment of Life Sciences Executive Keith W. ...
GlobeNewswire
06/10/2021
aTyr Pharma Announces Appointment of Robert W. Ashworth, PhD, as Vice President of Regulatory Affair...
GlobeNewswire
03/05/2021
Genenta to Appoint Richard Slansky as CFO and Anthony Marucci as Board Member
GlobeNewswire
19/04/2021
Daré Bioscience Appoints Dr. Sophia N. Ononye-Onyia to its Board of Directors
GlobeNewswire
24/01/2019
Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, In...
GlobeNewswire
22/08/2018
New Research: Key Drivers of Growth for OncoSec Medical, AcelRx Pharmaceuticals, Cameco, Prestige Br...
GlobeNewswire
13/08/2018
Gene Therapy Market, 2018-2030 - Around 300 Product Candidates Under Various Stages of Development f...
GlobeNewswire
30/07/2018
Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-...
GlobeNewswire
20/07/2018
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
GlobeNewswire
12/06/2018
Factors of Influence in 2018, Key Indicators and Opportunity within PPL, The Travelers Companies, Xi...
GlobeNewswire
16/02/2018
Analysis: Positioning to Benefit within Keane Group, Banc of California, Reinsurance Group of Americ...
GlobeNewswire
04/12/2017
Research Report Identifies Ascena Retail Group, OncoSec Medical, Discover Financial Services, Keane ...
